Information from Industry-Sponsored Supplement

Mycoplasma genitalium: A Pathogen We Can Finally Begin to Understand

DEVELOPED UNDER THE DIRECTION AND SPONSORSHIP OF HOLOGIC. THIS CONTENT WAS PREPARED BY THE SPECIALIZED CONTENT DIVISION OF FMC AND PEER REVIEWED BY OBG MANAGEMENT.

 

Riding alongside known STIs, this historically elusive microbe may have often been the underlying cause of a variety of symptoms. In this supplement to OBG Management Dr. Kyle Bukowski discusses how to meet the challenge presented by this not-so-new microbe while helping foster regular STI testing, and encourage patients to seek care when symptoms occur.

Click Here to Read the Supplement

Recommended Reading

Breast conservation safe even with multiple-site tumors
MDedge ObGyn
FDA approves OTC naloxone, but will cost be a barrier?
MDedge ObGyn
Surgical management of borderline ovarian tumors, part 1
MDedge ObGyn
Sweaty treatment for social anxiety could pass the sniff test
MDedge ObGyn
FDA panels vote to modify isotretinoin iPLEDGE REMS
MDedge ObGyn
Spotting STIs: Vaginal swabs work best
MDedge ObGyn
‘Excess’ deaths surging, but why?
MDedge ObGyn
The physician as leader
MDedge ObGyn
‘Startling’ cost barriers after abnormal screening mammogram
MDedge ObGyn
Frustration over iPLEDGE evident at FDA meeting
MDedge ObGyn